SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000892712-09-000975
Filing Date
2009-10-29
Accepted
2009-10-28 20:10:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 kiacellgen13da.htm SC 13D/A 80829
  Complete submission text file 0000892712-09-000975.txt   82793
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BOULEVARD SUITE 525 SOUTH SAN FRANCISCO CA 94080 650-266-3000
CELL GENESYS INC (Subject) CIK: 0000865231 (see all company filings)

IRS No.: 943061375 | State of Incorp.: DE | Fiscal Year End: 1017
Type: SC 13D/A | Act: 34 | File No.: 005-43085 | Film No.: 091142937
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7701 FRANCE AVENUE SOUTH STE 500 EDINA MN 55435
Business Address 7701 FRANCE AVENUE SOUTH STE 500 EDINA MN 55435 9528410400
KOPP INVESTMENT ADVISORS LLC (Filed by) CIK: 0000884306 (see all company filings)

IRS No.: 411663810 | State of Incorp.: MN | Fiscal Year End: 1231
Type: SC 13D/A